The molecular basis of prostate cancer cell escape from protoporphyrin IX-based photodynamic therapy

Medical Laser Application

Volumn 24, Issue 4, 2009, Pages 237-246

  Kammerer, Robert ^a,b   Palluch, Patrick ^a   Oboukhovskij, Konstantin ^a   Toelge, Mariana ^a   Pongratz, Thomas ^a   Beyer, Wolfgang ^a   Buchner, Alexander ^a,c   Baumgartner, Reinhold ^a   Zimmermann, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

5 Aminolevulinic acid; Immunotherapy; Oligonucleotide microarrays; Photodynamic therapy; Prostate cancer

Indexed keywords

5-AMINOLEVULINIC ACID; AFFYMETRIX; ALDO-KETO REDUCTASE; ANGIOGENESIS; ANTI-TUMOR IMMUNE; ANTITUMOR IMMUNITY; CELL DAMAGE; CHEMOKINES; CURRENT TECHNOLOGY; FIBROBLAST GROWTH FACTOR; GENE FAMILIES; HEAT SHOCK PROTEIN; HIGH DOSE; IMMUNOTHERAPY; IN-VITRO; INDUCED DAMAGE; LASER LIGHTS; MOLECULAR BASIS; MOLECULAR CHARACTERIZATION; MULTI-MODAL; OLIGONUCLEOTIDE MICROARRAY; OLIGONUCLEOTIDE MICROARRAYS; PROSTATE CANCER; PROSTATE CANCER CELLS; PROTOPORPHYRIN IX; QUALITY OF LIFE; REGULATED GENES; SOLID TUMORS; TRANSCRIPTOMES; TUMOR CELLS; TUMOR THERAPY; UP-REGULATION;

ACIDS; CELL CULTURE; CELL MEMBRANES; DRUG THERAPY; ENZYME ACTIVITY; GENE ENCODING; IMMUNOLOGY; OLIGONUCLEOTIDES; OPTICAL MATERIALS; PLASMONS; PROTEINS; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 70350567761     PISSN: 16151615     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mla.2009.07.001     Document Type: Article

References (27)

1. Gomella L.G., Johannes J., and Trabulsi E.J. Current prostate cancer treatments: effect on quality of life. Urology 73 5 Suppl. (2009) S28-S35
2. Moore C.M., Pendse D., and Emberton M. Photodynamic therapy for prostate cancer - a review of current status and future promise. Nat Clin Pract Urol 6 1 (2009) 18-30
3. Castano A.P., Mroz P., and Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6 7 (2006) 535-545
4. van Duijnhoven F.H., Aalbers R.I., Rovers J.P., Terpstra O.T., and Kuppen P.J. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207 2 (2003) 105-113
5. de Graaf Y.G., Kennedy C., Wolterbeek R., Collen A.F., Willemze R., and Bouwes Bavinck J.N. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 126 3 (2006) 569-574
6. Gollnick S.O., Evans S.S., Baumann H., Owczarczak B., Maier P., Vaughan L., et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88 11 (2003) 1772-1779
7. Kabingu E., Vaughan L., Owczarczak B., Ramsey K.D., and Gollnick S.O. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer 96 12 (2007) 1839-1848
8. Andrews N.W. Membrane repair and immunological danger. EMBO Rep 6 9 (2005) 826-830
9. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 23 11 (2002) 509-512
10. Seong S.Y., and Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4 6 (2004) 469-478
11. Casas A., Perotti C., Fukuda H., and del C Batlle A.M. Photodynamic therapy of activated and resting lymphocytes and its antioxidant adaptive response. Lasers Med Sci 17 1 (2002) 42-50
12. Gollnick S.O., Liu X., Owczarczak B., Musser D.A., and Henderson B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57 18 (1997) 3904-3909
13. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7 (2006) 3
14. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98 1 (2001) 31-36
15. Shedden K., Chen W., Kuick R., Ghosh D., Macdonald J., Cho K.R., et al. Comparison of seven methods for producing Affymetrix expression scores based on false discovery rates in disease profiling data. BMC Bioinform 6 (2005) 26
16. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4 5 (2003) P3
17. Huang da W., Sherman B.T., and Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4 1 (2009) 44-57
18. Ruhdorfer S., Sanovic R., Sander V., Krammer B., and Verwanger T. Gene expression profiling of the human carcinoma cell line A-431 after 5-aminolevulinic acid-based photodynamic treatment. Int J Oncol 30 5 (2007) 1253-1262
19. Buytaert E., Matroule J.Y., Durinck S., Close P., Kocanova S., Vandenheede J.R., et al. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 27 13 (2008) 1916-1929
20. Cekaite L., Peng Q., Reiner A., Shahzidi S., Tveito S., Furre I.E., et al. Mapping of oxidative stress responses of human tumor cells following photodynamic therapy using hexaminolevulinate. BMC Genomics 8 (2007) 273
21. Prasmickaite L., Cekaite L., Hellum M., Hovig E., Høgset A., and Berg K. Transcriptome changes in a colon adenocarcinoma cell line in response to photochemical treatment as used in photochemical internalisation (PCI). FEBS Lett 580 24 (2006) 5739-5746
22. Verwanger T., Sanovic R., Aberger F., Frischauf A.M., and Krammer B. Gene expression pattern following photodynamic treatment of the carcinoma cell line A-431 analysed by cDNA arrays. Int J Oncol 21 6 (2002) 1353-1359
23. Wild P.J., Krieg R.C., Seidl J., Stoehr R., Reher K., Hofmann C., et al. RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 4 4 (2005) 516-528
24. Cecic I., Stott B., and Korbelik M. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol 6 8 (2006) 1259-1266
25. Kousis P.C., Henderson B.W., Maier P.G., and Gollnick S.O. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res 67 21 (2007) 10501-10510
26. Frumento G., Piazza T., Di Carlo E., and Ferrini S. Targeting tumor-related immuno-suppression for cancer immunotherapy. Endocr Metab Immune Disord Drug Targets 6 3 (2006) 233-237
27. van Gisbergen K.P., Geijtenbeek T.B., and van Kooyk Y. Close encounters of neutrophils and DCs. Trends Immunol 26 12 (2005) 626-631